Commentators who have declared inequitable conduct dead and buried should study TransWeb, LLC v. 3M Innovative Properties Co., App. No. 2014-1646 (Fed. Cir., Feb. 10 2016). {A copy can be found at the end of this post.] The decision demonstrates how the “but-for materiality” and specific intent standards of the Therasense decision can open the […]
The post Therasense Puts A World Of (Antitrust) Hurt On 3M appeared first on Biotechnology Patent Law Blog | Patents4Life by Warren Woessner.